Trials / Recruiting
RecruitingNCT07285044
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Cancer CARE (Connected Access and Remote Expertise) Beyond Walls - Pilot, Phase 2 Clinical Trial to Evaluate Administration of Cancer-Directed Therapy in the Patient's Homes Versus in Clinic in the Florida Panhandle and Surrounding Areas
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 27 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This phase II trial studies whether providing cancer treatment in the home is preferred over the traditional clinic setting and if it improves treatment satisfaction in cancer patients living in the Florida Panhandle and surrounding areas. Typically, drug-related cancer care is provided at a medical center which causes patients to have to spend considerable time away from their family, friends, and familiar surroundings. This may add to the physical, emotional, social, and financial burden for patients and their families during this difficult time in their lives. The Cancer Connected Access and Remote Expertise (CARE) Beyond Walls (CCBW) program uses a specialized care team trained to provide cancer treatment in the patient's home setting. It is designed to support remote connection between the home health team and providers and Mayo clinic. This may be preferred over the traditional clinic setting which may improve treatment satisfaction in cancer patients living in the Florida Panhandle and surrounding areas.
Conditions
- Amyloidosis
- Basal Cell Carcinoma
- Biliary Tract Carcinoma
- Bladder Carcinoma
- Breast Carcinoma
- Cervical Carcinoma
- Colorectal Carcinoma
- Endometrial Carcinoma
- Fallopian Tube Carcinoma
- Gastroesophageal Junction Carcinoma
- Glioblastoma
- Head and Neck Carcinoma
- Hematopoietic and Lymphatic System Neoplasm
- Hepatocellular Carcinoma
- Hodgkin Lymphoma
- Lung Carcinoma
- Malignant Solid Neoplasm
- Mantle Cell Lymphoma
- Melanoma
- Merkel Cell Carcinoma
- Multiple Myeloma
- Myelodysplastic Syndrome
- Ovarian Carcinoma
- Pancreatic Carcinoma
- Primary Peritoneal Carcinoma
- Prostate Carcinoma
- Renal Cell Carcinoma
- Squamous Cell Carcinoma
- Urothelial Carcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cancer Therapeutic Procedure | Receive in-home standard of care cancer-treatment |
| DRUG | Cancer Therapeutic Procedure | Receive in-clinic standard of care cancer-treatment |
| OTHER | Questionnaire Administration | Ancillary studies |
Timeline
- Start date
- 2025-12-18
- Primary completion
- 2026-12-18
- Completion
- 2026-12-18
- First posted
- 2025-12-16
- Last updated
- 2025-12-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07285044. Inclusion in this directory is not an endorsement.